Viwit

Viwit

You are here: HomeProductsSitagliptin Phosphate Monohydrate

Contact us

  • Company Name: Viwit
  • Country/region: China
  • Contact Person: Mr.Keene Wei
  • Tel: 86-21-37775618
  • Email:

Sitagliptin Phosphate Monohydrate

  • CAS No:654671-77-9 Sitagliptin phosphate monohydrate
    Molecular Structure

    Detailed Description

    Sitagliptin (INN; i/s?t??ɡl?pt?n/, previously identified as MK-0431 and marketed as the phosphate salt under the trade name Januvia) is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck & Co. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its fewer side effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents such as metformin.